VIVOZON PHARMACEUTICAL CO., LTD.
Vivozon Pharmaceutical, founded in 2002 and KOSDAQ-listed in 2005, makes ETC/OTC drugs and runs CMO/OEM businesses across about 190 items.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureVivozon Pharmaceutical was founded in August 2002 and listed on KOSDAQ in November 2005 as a manufacturer and distributor of finished pharmaceuticals. Its lineup includes prescription drugs (ETC) such as 콜린세레이트정, 제이비카정, and 아토르바스타틴정, over-the-counter (OTC) products such as 라라올라, 리버타인, and 인버타인, the influenza treatment 셀타플루, and the new drug candidate 어나프라주. The company runs ETC, OTC, CMO (contract manufacturing), OEM, and overseas export businesses, carrying about 190 product items including gastrointestinal agents, anti-atherosclerotic agents, and central nervous system drugs.
Products & technology
- 콜린세레이트정cognitive function improvement
- 제이비카정antihypertensive
- 아토르바스타틴정cardiovascular agent
- 라라올라액fatigue recovery agent
- 리버타인액adjunct treatment for liver disease
- 내간애액liver disease agent
- 올디피정antihypertensive
- 제이카인크림local anesthetic
- 제이프로크림local anesthetic
- 셀타플루influenza treatment
- 어나프라주new drug candidate
Regulatory approvals
data.go.kr221 Korean MFDS drug approvals · 1981–2026 / 1 Korean MFDS device approvals · 2014
- MFDS drugLalafang Tab.2026-04-29Drug · Prescription · Approval202601288
- MFDS drugV-NO Tab. 10mg2026-04-23Drug · Prescription · Approval202601186
- MFDS drugV-NO Tab. 20mg2026-04-23Drug · Prescription · Approval202601187
- MFDS drugVIVACAP Tab. 50mg2026-04-14Drug · Prescription · Approval202601069
- MFDS drugVIVACAP Tab. 25mg2026-04-14Drug · Prescription · Approval202601070
- MFDS drugVIVOZON-ATORVASTATIN TAB.5mg2026-03-25Drug · Prescription · Approval202600844
- MFDS drugUnafra Injection2024-12-12Drug · Prescription · Approval202402947
- MFDS drugGINKGOLIFE TAB. 240mg2024-11-05Drug · OTC · Notification202402605
- MFDS drugLeblia topical solution(Efinaconazole)2024-08-19Drug · Prescription · Approval202401997
- MFDS drugNosejin Tab. 120mg2024-06-14Drug · OTC · Notification202401455
- MFDS drugNosejin Tab. 60mg2024-06-12Drug · OTC · Notification202401437
- MFDS drugV-gra Tab.100mg(Sildenafil Citrate)2024-05-31Drug · Prescription · Approval202401366
Show 68 more
- MFDS drugV-gra Tab.50mg(Sildenafil Citrate)2024-05-31Drug · Prescription · Approval202401367
- MFDS drugMebixa Tab. 20mg2024-04-30Drug · Prescription · Approval202401043
- MFDS drugJ-CAIN Gel. 10.56%(Lidocain)2023-12-07Drug · OTC · Approval202303303
- MFDS drugDapalozinDuo XR Tab. 10/1000mg2023-01-27Drug · Prescription · Approval202300354
- MFDS drugdapalozin Tab. 10mg2023-01-25Drug · Prescription · Approval202300330
- MFDS drugJanuvipo Tab. 10/100mg2023-01-11Drug · Prescription · Approval202300202
- MFDS drugIgliptin IR tab. 50/850mg2022-12-21Drug · Prescription · Approval202204603
- MFDS drugIgliptin IR tab. 50/500mg2022-12-21Drug · Prescription · Approval202204604
- MFDS drugIgliptin IR tab. 50/1000mg2022-12-21Drug · Prescription · Approval202204605
- MFDS drugVivozon Ciclopirox Nail Lacquer2022-08-18Drug · OTC · Notification202203312
- MFDS drugVivodion Inj.2022-07-19Drug · Prescription · Approval202202968
- MFDS drugIGLIPTIN XR TAB. 50/500mg2022-05-11Drug · Prescription · Approval202201936
- MFDS drugIGLIPTIN XR TAB. 50/1000mg2022-05-11Drug · Prescription · Approval202201937
- MFDS drugIGLIPTIN XR TAB. 100/1000mg2022-05-11Drug · Prescription · Approval202201938
- MFDS drugOmena Duo Tab. 20/800mg2021-06-24Drug · Prescription · Approval202104845
- MFDS drugAtrozet tab. 10/10mg2021-02-18Drug · Prescription · Approval202101637
- MFDS drugAtrozet tab. 10/40mg2021-02-18Drug · Prescription · Approval202101647
- MFDS drugAtrozet tab. 10/20mg2021-02-18Drug · Prescription · Approval202101651
- MFDS drugVIVOZON-MIRABEGRON PR TAB. 50mgRevoked2021-02-18Drug · Prescription · Approval202101471
- MFDS drugIgliptin tab. 25mg2021-02-16Drug · Prescription · Approval202101298
- MFDS drugIgliptin tab. 50mg2021-02-16Drug · Prescription · Approval202101299
- MFDS drugIGLIPTIN TAB. 100mg2021-02-16Drug · Prescription · Approval202101300
- MFDS drugDanapecia tablet 1mg(finasteride)2020-12-24Drug · Prescription · Approval202009181
- MFDS drugMELADIN PR Tab. 2mg(Melatonin)2020-09-22Drug · Prescription · Approval202006547
- MFDS drugXELFATINIB TAB. 5mgRevoked2020-09-07Drug · Prescription · Approval202006205
- MFDS drugCAXABAN TAB. 10mg2020-07-23Drug · Prescription · Approval202005289
- MFDS drugCAXABAN TAB. 15mg2020-07-23Drug · Prescription · Approval202005290
- MFDS drugLIDOSOLON CREAM(Prednisolone Valeroacetate)Revoked2020-06-18Drug · Prescription · Notification202004466
- MFDS drugLIDOSOLON CREAM 0.15%(Prednisolone Valeroacetate)Revoked2020-06-18Drug · OTC · Notification202004467
- MFDS drugDOUBLETAMS SR TAB. 0.4mg2020-04-24Drug · Prescription · Approval202003019
- MFDS drugGASTIZEN SR TAB.2020-04-17Drug · Prescription · Approval202002745
- MFDS drugCAXABAN TAB. 2.5mg2020-04-14Drug · Prescription · Approval202002652
- MFDS drugCAXABAN TAB. 20mg2020-04-14Drug · Prescription · Approval202002653
- MFDS drugINILAFUTIDINE TAB.Revoked2020-03-11Drug · Prescription · Approval202001693
- MFDS drugINIZENTA DUO TAB. 2.5/1000mgRevoked2020-03-05Drug · Prescription · Approval202001549
- MFDS drugINIZENTA DUO TAB. 2.5/850mgRevoked2020-03-05Drug · Prescription · Approval202001550
- MFDS drugINIZENTA DUO TAB. 2.5/500mgRevoked2020-03-05Drug · Prescription · Approval202001551
- MFDS drugINIZENTA TAB.2020-01-22Drug · Prescription · Approval202000382
- MFDS drugMATIRAN TAB. 40mg2019-10-23Drug · Prescription · Approval201907426
- MFDS drugINI-TENOFOVIR TAB.Revoked2019-09-24Drug · Prescription · Approval201906692
- MFDS drugMUREXIN SR Tab.(Eperisone hydrochloride)2019-08-21Drug · Prescription · Approval201905928
- MFDS drugVIVOZON-ADEFOVIR TAB. 10mgRevoked2019-08-16Drug · Prescription · Approval201905812
- MFDS drugANPLITE SR TAB. 300mg2019-05-28Drug · Prescription · Approval201903477
- MFDS drugCELELOX CAP. 100mg2019-05-27Drug · Prescription · Approval201903424
- MFDS drugVIVOZON-MONTELUKAST GLANULE 4mgRevoked2019-05-22Drug · Prescription · Approval201903333
- MFDS drugAceta Inj.2019-05-21Drug · Prescription · Approval201903300
- MFDS drugVIVOZON-RALOXIFENEHCl TAB.Revoked2019-05-14Drug · Prescription · Approval201903121
- MFDS drugTELMIDROP TAB.80mg2019-04-23Drug · Prescription · Approval201902497
- MFDS drugTELMIDROP TAB.40mg2019-04-23Drug · Prescription · Approval201902498
- MFDS drugMebixa Tab. 10mg2019-03-25Drug · Prescription · Approval201901764
- MFDS drugDUOCLO CREAM2019-03-21Drug · OTC · Notification201901708
- MFDS drugJ-VIKA HCT TAB. 5/40/12.5mg2019-02-25Drug · Prescription · Approval201901162
- MFDS drugBAZEVITA TAB.Revoked2019-01-29Drug · Prescription · Approval201900707
- MFDS drugJ-VIKA HCT TAB. 5/20/12.5mg2018-12-31Drug · Prescription · Approval201805389
- MFDS drugJ-VIKA HCT TAB. 10/40/12.5mg2018-12-31Drug · Prescription · Approval201805390
- MFDS drugINIVIT-D INJ.Revoked2018-11-06Drug · Prescription · Approval201804396
- MFDS drugVIVOZON-POLYSTYRENE POWD.Revoked2018-10-15Drug · Prescription · Notification201804022
- MFDS drugVIVOZON-COOL POWD.Revoked2018-10-10Drug · Prescription · Notification201803950
- MFDS drugZEROCOTIN TAB. 0.5mg2018-08-14Drug · Prescription · Approval201803330
- MFDS drugZEROCOTIN TAB. 1mg2018-08-14Drug · Prescription · Approval201803335
- MFDS drugALTHIOTMIN TAB. 480mg2018-04-16Drug · Prescription · Approval201801629
- MFDS drugINIBACILLUS CAP.2018-03-27Drug · OTC · Notification201801344
- MFDS drugL-CATIL TAB.2018-03-14Drug · OTC · Notification201801170
- MFDS drugCoetasone Nasal Spray2018-03-13Drug · Prescription · Notification201801154
- MFDS drugInibacillus pow.2018-03-12Drug · OTC · Notification201801116
- MFDS drugELIXABAN TAB 5mg2018-01-26Drug · Prescription · Approval201800474
- MFDS drugELIXABAN TAB 2.5mg2018-01-26Drug · Prescription · Approval201800475
- MFDS drugNOTENSION TAB. 2.5mg2018-01-04Drug · Prescription · Approval201800048
Showing the 80 most recent of 222 records.
Clinical trials
data.go.kr53 MFDS clinical trial authorisations · 2012–2025 (Bioequivalence 48 · Phase 3 2 · Phase 2 1 · Phase 1/2a 1 · Phase 1 1)
- BioequivalenceVVZP25012025-11-26
2 trial sites
- BioequivalenceVVZP25012025-11-26
2 trial sites
- BioequivalenceVVZP25022025-11-20
2 trial sites
- Bioequivalence피아젯정4/10mg(피타바스타틴, 에제티미브)2025-04-07
2 trial sites
- Bioequivalence에녹사반정60밀리그램(에독사반토실산염수화물)2024-10-14
2 trial sites
- Bioequivalence아트로젯정10/40밀리그램2024-07-25
2 trial sites
- Bioequivalence브이노정20밀리그램(보노프라잔푸마르산염)2024-04-16
2 trial sites
- Bioequivalence비보존페노콜린정2024-02-08
2 trial sites
- Bioequivalence비보존페노콜린정2024-02-06
2 trial sites
- Phase 3비보락사정2024-01-24
6 trial sites
- Bioequivalence레티스정(펜터민염산염)2023-04-04
2 trial sites
- Bioequivalence디에트정(펜디메트라진타르타르산염)2023-03-27
2 trial sites
Show 41 more
- Bioequivalence브이그라정100밀리그램(실데나필시트르산염)2023-03-07
2 trial sites
- Phase 2오피란제린크림2022-02-28
3 trial sites
- Bioequivalence파모젠정(파모티딘)2022-02-15
2 trial sites
- Phase 3VVZ-149 주사2021-02-22
6 trial sites
- Bioequivalence셀레록스캡슐(세레콕시브)2020-10-15
1 trial site
- Bioequivalence다파로진정10밀리그램(다파글리플로진프로판디올수화물)2020-07-07
2 trial sites
- Bioequivalence이니스트클로피도그렐정75mg(클로피도그렐황산수소염)2020-02-24
2 trial sites
- Bioequivalence오메플정40mg2020-01-20
2 trial sites
- Bioequivalence이니스트몬테루카스트정10mg(몬테루카스트나트륨)2019-12-27
2 trial sites
- Bioequivalence슈바스틴정20mg(로수바스타틴칼슘)2019-10-14
2 trial sites
- Bioequivalence팜비나정(팜시클로비르)2019-09-25
2 trial sites
- Bioequivalence이니아토에제정10/40밀리그램(가칭)2019-09-23
2 trial sites
- Bioequivalence슈바텔미정80/20밀리그램2019-07-17
2 trial sites
- Phase 1/2a오피란제린크림2019-04-25
2 trial sites
- Bioequivalence멜라딘서방정2mg(멜라토닌)2019-03-28
2 trial sites
- Bioequivalence멜라딘서방정2mg(멜라토닌)2019-03-27
2 trial sites
- Bioequivalence이니스트아토르바스타틴정20mg(아토르바스타틴칼슘삼수화물)2018-08-28
2 trial sites
- Bioequivalence제이비카HCT정 5/20/12.5 밀리그램(가칭)2018-03-09
2 trial sites
- Bioequivalence콜린세레이트액(가칭)2017-12-21
2 trial sites
- Phase 1INI17012017-12-12
1 trial site
- Bioequivalence제이비카HCT정(가칭)2017-11-13
2 trial sites
- Bioequivalence오메플정40mg2017-11-13
2 trial sites
- Bioequivalence알러퀵정20밀리그램(에피나스틴염산염)2017-10-26
2 trial sites
- Bioequivalence이니알티옥트산정480mg(가칭)(알티옥트산트로메타민염)2017-05-15
2 trial sites
- Bioequivalence이니스트오셀타미비르 현탁용분말 6mg/mL(가칭)(오셀타미비르인산염)2017-02-27
2 trial sites
- Bioequivalence이니스트아픽사반정(가칭)2017-02-13
2 trial sites
- Bioequivalence이니티카그렐러정90mg(가칭)2016-12-29
2 trial sites
- Bioequivalence이니스트베포타스틴정(가칭)2016-11-08
- Bioequivalence이니스트나프토피딜정75mg2016-10-28
1 trial site
- Bioequivalence이니스트콜린알포세레이트정2016-06-30
2 trial sites
- Bioequivalence이니스트오셀타미비르캡슐75mg2015-10-28
2 trial sites
- Bioequivalence제이알레바미피드정2015-06-23
2 trial sites
- Bioequivalence제이페북소정80밀리그램2015-01-22
2 trial sites
- Bioequivalence제이실로신캡슐4밀리그램2014-12-17
2 trial sites
- Bioequivalence제이타다라필정 20밀리그램(타다라필)2014-12-17
2 trial sites
- Bioequivalence제이비스정2013-10-21
- Bioequivalence에스라졸정40밀리그램2013-07-18
2 trial sites
- Bioequivalence제이비카정 10/40밀리그램2013-05-16
2 trial sites
- Bioequivalence제이비스정2013-01-03
- Bioequivalence가스토텍정(미소프로스톨)2012-12-12
2 trial sites
- Bioequivalence제이포지정2012-10-26
R&D and key agreements
Source: DART corporate disclosure듀오클로크림 · 일반의약품 · 출시(2019)
몬테루카스트정, 셀레록스캡슐 · 생동성 확보(2021)
브이그라정 · 생동성 확보(2022), 품목허가 완료(2024)
에빅사정20mg · 동등성시험 확보(2023)
디에트정(향정) · 생동성 확보(2023)
비보존에르도스테인캡슐 · 동등성시험 확보(2024)
메빅사정20mg · 품목허가 승인(2024)
브이노정 · 생동성 확보(2024)
Companies approved for the same productsPharma & CDMO
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
Founded in 1963 and listed in 1988, Boryung is a pharmaceutical and CDMO firm built around its antihypertensive drug Kanarb.
Founded in 1996 and listed on KOSDAQ in 1999, ChoA Pharmaceutical is an OTC-focused drugmaker exporting to 23 countries worldwide.
KOSDAQ-listed IVD company producing COVID-19 and HIV point-of-care diagnostic reagents alongside rubber products and entertainment businesses.
Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.
KOSPI-listed pharmaceutical company known for its anti-ulcer drug Noltec and leukemia treatment Supect (radotinib).
Founded in 1945, JW Pharmaceutical holds an original drug pipeline including Rivalo and Hemlibra, plus the IV nutrition product Winuf and OTC brand Hwakol.
Kwangdong Pharmaceutical, founded in 1963 and KOSPI-listed in 1989, manufactures prescription drugs and beverages.
Founded in 1998, Kyungnam Pharm is a pharmaceutical and health-food company known for the vitamin brand Lemona and placenta drink Jahasaengryeok.
KOSDAQ-listed molecular genetic diagnostics company providing NGS-based non-invasive prenatal testing (NIPT) under the MomGuard brand.
Founded in 1987 and listed on KOSDAQ in 2000, NanoenTek develops Lab-On-a-Chip in-vitro diagnostic devices and life science instruments.
KOSDAQ-listed in-vitro diagnostics company selling PROTIA Allergy-Q allergy diagnostic products domestically and in 80+ countries.
Sam-A Pharm, founded in 1973 and KOSDAQ-listed in 2000, manufactures prescription pharmaceuticals.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition